New study uses wearable ECG to catch hidden heart problems after TAVI

NCT ID NCT04298593

Ongoing Knowledge-focused Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 200 people who had a heart valve replacement (TAVI) to see how often they experience heart rhythm problems in the weeks after the procedure. Participants wear a portable ECG monitor for up to 4 weeks after leaving the hospital. The goal is to learn how common these rhythm issues are and whether early detection leads to changes in treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CardioSTAT continuous ECG monitoring device
What this could lead to: If successful, this could show that home ECG monitoring after TAVI helps catch heart rhythm issues early, leading to quicker treatment adjustments.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. It may not prove that monitoring changes long-term health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ECG MONITORING TAVI

Contacts and locations

Locations

IUCPQ

Québec, Quebec, G1V 4G5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.